| # | Drug | Count |
|---|---|---|
| 0 | EPOPROSTENOL | 564 |
| 1 | TREPROSTINIL | 551 |
| 2 | SILDENAFIL CITRATE | 496 |
| 3 | MACITENTAN | 420 |
| 4 | TADALAFIL | 387 |
| 5 | AMBRISENTAN | 336 |
| 6 | SILDENAFIL | 332 |
| 7 | FOSCARBIDOPA/FOSLEVODOPA | 197 |
| 8 | FUROSEMIDE | 188 |
| 9 | SILDENAFIL POWDER, | 183 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EPOPROSTENOL | 564 | 0.0430 |
| 1 | FOSCARBIDOPA/FOSLEVODOPA | 197 | 0.0223 |
| 2 | MACITENTAN | 420 | 0.0060 |
| 3 | SOTATERCEPT-CSRK | 33 | 0.0053 |
| 4 | SILDENAFIL POWDER, | 183 | 0.0051 |
| 5 | RIOCIGUAT | 142 | 0.0043 |
| 6 | TREPROSTINIL | 551 | 0.0043 |
| 7 | SILDENAFIL CITRATE | 496 | 0.0039 |
| 8 | TADALAFIL | 387 | 0.0038 |
| 9 | IDURSULFASE | 14 | 0.0035 |
| # | Drug class | Count |
|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 1053 |
| 1 | Endothelin Receptor Antagonist [EPC] | 731 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 544 |
| 3 | Loop Diuretic [EPC] | 237 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 209 |
| 5 | Osmotic Laxative [EPC] | 175 |
| 6 | Factor Xa Inhibitor [EPC] | 168 |
| 7 | Corticosteroid [EPC] | 157 |
| 8 | Soluble Guanylate Cyclase Stimulator [EPC] | 142 |
| 9 | Aldosterone Antagonist [EPC] | 130 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 1053 | 0.0076 |
| 1 | Soluble Guanylate Cyclase Stimulator [EPC] | 142 | 0.0042 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 544 | 0.0040 |
| 3 | Endothelin Receptor Antagonist [EPC] | 731 | 0.0036 |
| 4 | Guanylate Cyclase-C Agonist [EPC] | 7 | 0.0034 |
| 5 | Provitamin D2 Compound [EPC] | 96 | 0.0032 |
| 6 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 32 | 0.0024 |
| 7 | Prostacyclin Receptor Agonist [EPC] | 58 | 0.0022 |
| 8 | Autologous Cellular Immunotherapy [EPC] | 12 | 0.0021 |
| 9 | Catechol-O-Methyltransferase Inhibitor [EPC] | 10 | 0.0020 |